Patient-reported well-being: psychometric properties of the world health organization well-being index in specialised community mental health settings

2020 ◽  
Vol 291 ◽  
pp. 113268
Author(s):  
Mariela L. Lara-Cabrera ◽  
Ingunn Pernille Mundal ◽  
Carlos De Las Cuevas
2021 ◽  
Vol 36 (1) ◽  
pp. 14-24
Author(s):  
Miguel A. Pérez ◽  
Julio Cesar Cerna Cano ◽  
Luz Marina Alonso-Palacio ◽  
Edgardo Chacón-Andrade

The World Health Organization (WHO) defines mental health as “a state of well-being in which the individual realizes his or her own abilities, can cope with the normal stresses of life, can work productively and fruitfully, and is able to make a contribution to his or her community”1. Consequently, mental health is a construct composed of psychological, emotional, social and environmental issues which includes a person’s ability to function under adversity and also to adapt to changes around them.


2018 ◽  
Vol 40 (2) ◽  
pp. 79-84 ◽  
Author(s):  
Mahboubeh Dadfar ◽  
Nahid Momeni Safarabad ◽  
Ali Asghar Asgharnejad Farid ◽  
Monir Nemati Shirzy ◽  
Farzad Ghazie pour Abarghouie

Abstract Introduction: The association between psychological well-being and physical and mental health has been shown in the literature. Psychological well-being is a multifaceted concept. The World Health Organization-5 Well-Being Index (WHO-5) is a 5-item instrument used to screen for depression. However, the validity of the WHO-5 has not been investigated in Iranian psychiatric or psychological settings. Objective: To investigate the validation of the Farsi version of the WHO-5 in a sample of Iranian psychiatric outpatients. Methods: A cross-sectional study was conducted with a convenience sample of 116 Iranian volunteer psychiatric outpatients selected from the psychiatric and psychological clinics at the School of Behavioral Sciences and Mental Health - Tehran Institute of Psychiatry, Iran University of Medical Sciences. Patients completed the WHO-5, the Patient Health Questionnaire-9 (PHQ-9), the Patient Health Questionnaire-15 (PHQ-15), and the short form of the Beck Depression Inventory-13 (BDI-13). Results: The mean score of the WHO-5 was 8.95 (standard deviation [SD] = 5.49). Cronbach's α for the WHO-5 was 0.91. The WHO-5 negatively correlated with PHQ-9 (-0.358), PHQ-15 (-0.328), and BDI-13 (-0.475), indicating good validity. Factor analysis of the WHO-5 items identified one factor labeled psychological well-being. Conclusions: The WHO-5 has a single dimensional structure and acceptable psychometric parameters. The results of this study suggest that WHO-5 can be used in a clinical context in Iran.


2018 ◽  
Vol 7 ◽  
Author(s):  
Christine Peta

In 2016, the World Health Organization, through the Global Cooperation on Assistive Technology Initiative, issued the Priority Assistive Products List which is meant to be a guide to member states of the 50 assistive products needed for a basic health care and/or social welfare system; it is also a model from which nations can develop their national priority assistive products lists. The aim of this opinion paper is to share my views about the Priority Assistive Products List on the grounds that it makes no distinct mention of sexual assistive devices, yet research has indicated that sexuality is an area of great concern for persons with disabilities. In any case, sexuality forms a core part of being human, and it impacts on both the physical and mental well-being of all human beings. I conclude in part that, in its present format, the list perpetuates the myth that persons with disabilities are asexual beings who are innocent of sexual thoughts, feelings and experiences. The list also propagates the stereotype that sexuality is a sacred, private, bedroom matter that should be kept out of the public domain, to the detriment of the health and well-being of persons with disabilities.


2021 ◽  
pp. 172-180
Author(s):  
Fitrio Deviantony ◽  
Grysha Viofananda ◽  
Nurul Hidayah ◽  
Nadhifa Eriyanti

permasalahan serius di dunia dan Indonesia. Data dari World Health Organization sekitar 21 juta orang mengalami skizofrenia. Prevalensi skizofrenia di Indonesia mengalami peningkatan proporsi per 1000 penduduk (1,7%) pada tahun 2013 menjadi (7%) pada tahun 2018. Faktanya terapi keperawatan untuk halusinasi belum optimal sedangkan teknologi terus berkembang seperti Virtual Reality (VR). VR mampu menurunkan gejala pada skizofrenia dengan kemampuan membuat perilaku interaktif dan tersimpan dalam otak agar tidak menimbulkan halusinasi. Teknologi ini digunakan untuk mengetahui manfaat E-Health Nursing VR sebagai terapi halusinasi pada pasien skizofrenia. Metode penelitian menggunakan systematic review dari 5 database yaitu Nature, Frontiers, BMC, Science Direct, NEJM sehingga didapat total 55 literatur. Mayoritas 63% mengulas terapi VR untuk mengurangi halusinasi pada skizofrenia. Perkembangan manfaat VR diverifikasi dalam beberapa pengobatan: skizofrenia, PTSD, kecemasan, akrofobia, ganguan citra tubuh, claustrophobia, dan lain-lain. Beberapa studi skizofrenia menyatakan terapi VR sangat efektif menangani delusi, halusinasi, gejala kepribadian skizoid. VR juga berguna dalam rehabilitas kognitif pada orang dewasa atau anak-anak autis dalam keterampilan dan kemandirian. Kesimpulan penelitian ini adalah VR terbukti efektif sebagai terapi kesehatan jiwa di masa mendatang. Disisi lain terdapat terapi psikologis pilihan seperti terapi perilaku kognitif, dan psikoterapi interpersonal. Oleh karenanya diperlukan kombinasi terapi VR dengan terapi komplementer tersebut dalam mengurangi halusinasi pada skizofrenia.   Mental health become a severe problem in the world and Indonesia. Data from the World Health Organization (WHO, 2016) estimated that 21 million people have schizophrenia. The prevalence of schizophrenia in Indonesia has increased proportion per 1000 population (1,7%) in 2013 to (7%) in 2018. In fact of nursing, therapy for hallucination is not optimal while constantly evolving technology such as Virtual Reality (VR). VR can reduce symptoms in schizophrenia with the ability to create interactive behavior and stored in the brain in order to cause hallucinations. The objective of this study was to review the benefit of VR as a hallucination therapy in schizophrenia patients. This research used a systematic literature review from five databases Nature, Frontiers, BMC, Science Direct, NEJM, and resulted in the retrieval of 55 papers. The majority of a result found a 63% review in Virtual Reality therapy can reduce hallucination in schizophrenia. VR is a technology browser and manipulator sensory environment in real-time 3D. The progressing benefit of VR verified in the treatment of schizophrenia, PSTD, anxiety, acrophobia, body image disorder, claustrophobia, and others. Some studies of schizophrenia declare that virtual reality therapy is effective in treating delusions, hallucinations, and a symptom of schizoid behavior. VR also has benefits in cognitive rehabilitation in adults or children with autism's inability and self-reliance. VR has a bright future as the treatment of mental health. The progressing of technology and research has an excellent opportunity for VR to reduce schizophrenia. Moreover, there is psychological therapy, such as cognitive-behavioral therapy and interpersonal psychotherapy. Therefore a combination needed of virtual therapy with the complementary therapy for reducing hallucination in schizophrenia.


2019 ◽  
Vol 28 (2) ◽  
pp. e1761 ◽  
Author(s):  
Pim Cuijpers ◽  
Randy P. Auerbach ◽  
Corina Benjet ◽  
Ronny Bruffaerts ◽  
David Ebert ◽  
...  

2019 ◽  
Vol 11 (2) ◽  
pp. 76-83
Author(s):  
Jesmin Sultana ◽  
Muhammad Rabiul Hossain ◽  
Nurun Nahar Fatema Begum ◽  
Nure Ishrat Nazme

 Breastfeeding has been accepted as the most vital intervention for reducing infant mortality and ensuring optimal growth and development of children. Breastfeeding is also considered as the most economical and easily accessible complete nutrition for every new born child1. Poor breastfeeding practices are widespread. It is estimated that sub-optimal breastfeeding, especially non-exclusive breastfeeding in the first 6 months of life, results in 1.4 million deaths and 10% of the disease burden in children younger than 5 years of age2. Reviews of studies from developing countries showed that infants who were not breast fed were 6 to 10 times more likely to die in the first months of life than infants who are breast fed3. The World Health Organization has stated that in 2000, only 16% of mothers in Pakistan exclusively breast feed for a period of three months, as compared to other developing countries where the ratio is higher like Bangladesh (46%), India (37%), and Sri Lanka (84%)4. More than 15% of 24 lakh child deaths could be averted in India by optimal breastfeeding practices5. The key to successful breastfeeding is Information, Education and Communication (IEC) strategies aimed at behavior change6. The World Health Organization (WHO) and United Nations Children’s Fund (UNICEF) strongly recommends exclusive breastfeeding (EBF) for the first six months of life7. Variables that may influence breastfeeding include race, maternal age, maternal employment, level of education of parents, socio-economic status, insufficient milk supply, infant health problems, method of delivery, maternal interest and other related related factors8,9. Over the last decade, overwhelming scientific evidence supporting the integral role of breastfeeding in the survival, growth and development of a child, as well as the health and well-being of a mother has come to light10. Different studies were designed at national and international level to explore the knowledge, attitude and practices (kap) towards breastfeeding among postnatal mothers and factors that determine them1. Journal of Armed Forces Medical College Bangladesh Vol.11(2) 2015: 76-83


Sign in / Sign up

Export Citation Format

Share Document